Tarfa A. Altorki
Jeddah, Saudi Arabia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Broadly Protective Antibody-Like Vaccines Against Highly Pathogenic Coronaviruses.
Journal: Journal of medical virology
Published: October 06, 2025
Harnessing SARS-CoV-2 immunity to promote antitumor responses through intratumoral vaccination and adoptive transfer.
Journal: Frontiers in immunology
Published: September 23, 2025
Cost-Effective and Time-Saving Multiplex-Beads Immunoassay Method to Detect Humoral Immune Responses Against Respiratory Infections.
Journal: Journal of immunology research
Published: August 15, 2025
Intranasal CD40-targeted recombinant MERS-CoV S1 protein is superior to intramuscular immunization in eliciting systemic and mucosal immune responses in mice.
Journal: Vaccine
Published: July 14, 2025
Mucosal SARS-CoV-2 S1 adenovirus-based vaccine elicits robust systemic and mucosal immunity and protects against disease in animals.
Journal: mBio
Published: December 04, 2024
Bloodstream infections caused by Staphylococcus aureus in patients admitted to King Abdulaziz University Hospital, Jeddah, Saudi Arabia.
Journal: European review for medical and pharmacological sciences
Published: December 03, 2024
Dynamic Challenges of Active Tuberculosis: Prevalence and Risk Factors of Co-Infection in Clinical and Microbiological Characteristics at King Abdulaziz University Hospital, Jeddah, Saudi Arabia.
Journal: International journal of general medicine
Published: October 06, 2024
Correction: Helminth-derived proteins as immune system regulators: a systematic review of their promise in alleviating colitis.
Journal: BMC immunology
Published: October 04, 2024
Novel quinoxaline compound against extended-spectrum beta-lactamases producing bacteria.
Journal: European review for medical and pharmacological sciences
Published: June 10, 2024
Robust memory humoral immune response to SARS-CoV-2 in the tonsils of adults and children.
Journal: Frontiers in immunology
Published: September 09, 2023
A Modified Recombinant DNA-Based SARS-CoV-2 Vaccine Expressing Stabilized Uncleavable Spike Protein Elicits Humoral and Cellular Immunity against Various SARS-CoV-2 Variants of Concern.
Journal: Transboundary and emerging diseases
Published: April 13, 2023
Last Updated: 09/26/2026